Viewing Study NCT05689034


Ignite Creation Date: 2025-12-25 @ 2:23 AM
Ignite Modification Date: 2026-01-26 @ 11:55 PM
Study NCT ID: NCT05689034
Status: RECRUITING
Last Update Posted: 2024-11-25
First Post: 2023-01-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness
Sponsor: Peking Union Medical College Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-04-19
Start Date Type: ACTUAL
Primary Completion Date: 2025-06-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2023-01-17
First Submit QC Date: None
Study First Post Date: 2023-01-18
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-11-21
Last Update Post Date: 2024-11-25
Last Update Post Date Type: ACTUAL